Background Conflicting findings exist on the mechanisms of resistin in obesity and insulin resistance among white populations, as data on these in black Africans are scarce, on account of genetic/geographical differences. Hence, the study aimed to determine plasma resistin levels in Nigerian-Africans and explore its relationship with obesity and selected cardiometabolic risks. Materials and Methods A cross-sectional study on 87 randomly-selected non-diabetes Nigerians of both genders allocated into three study groups: 24 normal weight; 23 overweight and 40 obese groups by the WHO criteria. Fasting Insulin (FI), Homeostasis Model Assessment-Insulin resistance (HOMA-IR) and obesity indices were determined. Plasma resistin was measured via enzyme linked immunosorbent assay. One-way Kruskal-Wallis test determined cardiometabolic parameters across the groups with Spearman’s correlation assessing relationships. Results Resistin levels were higher in overweight and obese than normal weight subjects {6.6±3.8, 6.7±4.2 versus 5.6±2.9 µIU/mL, ( p<0.001 )}, with highest concentrations in severely obese than mildly and non-obese subjects {(7.4±5.6 versus 6.7±4.2 versus 6.05±3.0 µIU/mL ( p<0.001 , One-way Kruskal-Wallis). However, resistin showed no significant ( p>0.05 ) correlations to HOMA-IR, FI and obesity indices. The higher HOMA-IR found in overweight and obese than normal weight subjects (3.7±3.5, 2.9±2.4 vs. 2.1±0.4, p<0.001 ), was positively correlated to obesity and FI, which also increased from mild to severe BMI categories. Conclusion Higher resistin concentrations are found in severe obesity among non-diabetes black Africans, but its lack of correlation with insulin resistance and obesity indices may suggests possible interplay of other pro-inflammatory cytokines or hormones which may be evaluated in further studies.